268 related articles for article (PubMed ID: 2578868)
1. Studies on circulating antibody against carcinoembryonic antigen (CEA) and CEA-like antigen in cancer patients.
Ura Y; Ochi Y; Hamazu M; Ishida M; Nakajima K; Watanabe T
Cancer Lett; 1985 Jan; 25(3):283-95. PubMed ID: 2578868
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical identification of an alpha 1-acid glycoprotein-antigenic determinant on carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA).
Ochi Y; Ura Y; Hamazu M; Fujiyama Y; Kajita Y; Ishida M; Miyazaki T; Tamura K
Clin Chim Acta; 1984 Mar; 138(1):9-19. PubMed ID: 6201306
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
Matsuoka Y; Kuroki M; Koga Y; Kuriyama H; Mori T; Kosaki G
Cancer Res; 1982 May; 42(5):2012-8. PubMed ID: 6175402
[TBL] [Abstract][Full Text] [Related]
4. CEA and NCA in benign and malignant breast tumors.
Nap M; Keuning H; Burtin P; Oosterhuis JW; Fleuren G
Am J Clin Pathol; 1984 Nov; 82(5):526-34. PubMed ID: 6388310
[TBL] [Abstract][Full Text] [Related]
5. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera.
Frénoy N; Schauffler J; Cahour A; Burtin P
Anticancer Res; 1987; 7(6):1229-33. PubMed ID: 3327450
[TBL] [Abstract][Full Text] [Related]
6. Reaction profiles of seven enzyme immunoassay kits for carcinoembryonic antigen (CEA) analyzed with purified preparations of CEA and related normal antigens.
Kuroki M; Haruno M; Arakawa F; Wakisaka M; Matsuoka Y
Clin Biochem; 1992 Feb; 25(1):29-35. PubMed ID: 1551238
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
Kuroki M; Kuroki M; Koga Y; Matsuoka Y
J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of a 50,000 mol. wt glycoprotein antigen, and localization of determinants involved in cross-reactivity with carcinoembryonic antigen.
Laferté S; Krantz MJ
Mol Immunol; 1983 Apr; 20(4):421-31. PubMed ID: 6191208
[TBL] [Abstract][Full Text] [Related]
9. Epitopes of carcinoembryonic antigen (CEA) defined by monoclonal antibodies.
Price MR
Br J Cancer; 1988 Feb; 57(2):165-9. PubMed ID: 2451932
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities.
Suzuki N; Kondo K; Tominaga S; Kuroki M; Matsuoka Y
Cancer Res; 1987 Sep; 47(18):4782-7. PubMed ID: 2441854
[TBL] [Abstract][Full Text] [Related]
11. Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas.
Robbins PF; Eggensperger D; Qi CF; Schlom J
Int J Cancer; 1993 Apr; 53(6):892-7. PubMed ID: 8386136
[TBL] [Abstract][Full Text] [Related]
12. Association of the Y hapten with glycoproteins, glycolipids and carcinoembryonic antigen in colorectal carcinoma.
Price MR; Edwards S; Baldwin RW
Cancer Lett; 1986 Oct; 33(1):83-9. PubMed ID: 3768863
[TBL] [Abstract][Full Text] [Related]
13. Immunological heterogeneity of carcinoembryonic antigen: antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies.
Primus FJ; Newell KD; Blue A; Goldenberg DM
Cancer Res; 1983 Feb; 43(2):686-92. PubMed ID: 6184152
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
Audette M; Buchegger F; Schreyer M; Mach JP
Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
[TBL] [Abstract][Full Text] [Related]
15. [Antigenic structure of NCA-2 from meconium and comparison with normal fecal antigen from adult feces and carcinoembryonic antigen from malignant tissues].
Kuriyama H
Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):301-9. PubMed ID: 6201714
[TBL] [Abstract][Full Text] [Related]
16. Production kinetics and immunochemical properties of carcinoembryonic antigen and nonspecific cross-reacting antigen synthesized by various human tumor cell lines.
Ichiki S; Kuroki M; Kuroki M; Koga Y; Matsuoka Y
Jpn J Cancer Res; 1986 May; 77(5):462-72. PubMed ID: 2426231
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody against a CEA-related antigen expressed on HT29 colon tumour cells.
Rogers GT; Rawlins GA; Kardana A; Gibbons AR; Bagshawe KD
Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1279-86. PubMed ID: 6208034
[TBL] [Abstract][Full Text] [Related]
18. Specificities and binding properties of eight monoclonal antibodies against carcinoembryonic antigen.
Hedin A; Hammarström S; Larsson A
Mol Immunol; 1982 Dec; 19(12):1641-8. PubMed ID: 6186908
[TBL] [Abstract][Full Text] [Related]
19. Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies.
Primus FJ; Kuhns WJ; Goldenberg DM
Cancer Res; 1983 Feb; 43(2):693-701. PubMed ID: 6184153
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies for carcinoembryonic antigen (CEA) as a model system: identification of two novel CEA-related antigens in meconium and colorectal carcinoma tissue by Western blots and differential immunoaffinity chromatography.
Neumaier M; Fenger U; Wagener C
J Immunol; 1985 Nov; 135(5):3604-9. PubMed ID: 4045198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]